Clinical Trial Update: A Study Evaluating Effects of Intranasal JNJ-17166864 on Symptoms of Allergic Rhinitis in Adults [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating intranasal JNJ-17166864 for symptoms of allergic rhinitis in adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• JNJ-17166864

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Allergic Rhinitis | Phase 2 | Status: COMPLETED